Clinical Trials Browser

Diffuse Intrinsic Pontine Glioma

NCT02655536 2018-07-10

BRILLIANT

Phase 2 Unknown

109 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT01763385 2014-12-23

TRACTS

Phase 2 Unknown

210 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00054496 2014-01-10

Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme

Phase 2 Unknown

73 enrolled

CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00360854 2013-09-20

Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma

Phase 1 Unknown

48 enrolled

CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma

NCT01158170 2010-07-08

Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)

Phase 3 Unknown

200 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT01130779 2010-05-26

The Continuation of Erlotinib

Phase 2 Unknown

23 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00663689 2008-04-22

Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer

Phase 2 Unknown

45 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Clinical Trials

BIOMEDE

BRILLIANT

TRACTS

Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme

Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma

Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)

The Continuation of Erlotinib

Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer